The Latest

The Regulatory Catalyst: Removing The Identity BarrierIn December 2025, the FDA issued a final guidance that fundamentally changed how it evaluates Real-World Evidence (RWE). For years, the agency largely required "identifiable" patient-level data — specific names or social security numbers — to verify the accuracy of medical studies. Because privacy laws (HIPAA) and security protocols often require data to be de-identified, this created a structural barrier that disqualified vast amounts of highvalue clinical information from being used for drug or device approvals.The new mandate removes this requirement. Commissioner Marty Makary has characterized this as a shift toward "radical transparency," where the agency no longer asks "Who is the patient?" but rather "Is the data true?". The FDA will now accept de-identified datasets, provided the source can prove the information is accurate, reliable, and scientifically sound.The Evidence Gap: Administrative Proxies VS. Ground TruthWhile this "unlocks" massive amounts of data, it also exposes a significant flaw in current healthcare systems. Most medical data today consists of "administrative proxies"— billing codes, insurance claims, and fragmented notes captured for the purpose of payment. These proxies are often inaccurate and lack the clinical depth required for federal audits or highstakes licensing.To take advantage of this new regulatory path, organizations must move toward Regulatory-Grade Governance. This means defining the data architecture and clinical guardrails before the patient encounter begins. By using Circles’ Observational Protocols (OPs), providers create an Audit-Ready "Ground Truth" that makes billing errors or protocol deviations technically impossible.The Economic Model: From Service To AssetThis shift transforms the clinical record. Historically, documentation has been a regulatory burden — a cost center. In the new FDA environment, verified data becomes a high-margin, licensable asset.The Circles platform provides the infrastructure for this transformation across any medical specialty — from oncology to neurology. By capturing Standardized Longitudinal Scores and objective outcomes at the point of care, Circles ensure that every patient encounter generates Verified Clinical Veracity. This data does not just meet the new FDA standard; it exceeds it, providing the Insurable Integrity that allows for faster approvals and lower liability risks.Strategic Outcome: Valuation ExpansionFor Management Services Organizations (MSOs) and healthcare boards, the objective is Multiple Expansion. By transitioning from a "Service Business" focused on volume to a "Tech-Enabled Asset" focused on high-veracity data, organizations can significantly increase their valuation multiples. The value of the enterprise is no longer just in the procedure performed, but in the Insurable Integrity of the evidence created.

The Cult Of MagnitudeIn the mythology of machine learning, scale equals truth. We are told that the more data a model consumes, the more “generalizable” its intelligence becomes. In medicine, this logic has become gospel — aggregating millions of records, billions of data points, all to simulate the judgment of a single good clinician. But the assumption is flawed.Scale amplifies patterns; it does not clarify meaning. When bias, incompleteness, or error arealready present, multiplying them by a million produces not insight but illusion — the statistical equivalent of shouting nonsense louder.The Diminishing Returns Of VolumeEmpirically, performance gains in large models plateau long before ethical or clinicalreliability is reached. Beyond a threshold, each additional terabyte adds noise faster thansignal, correlation faster than causation. More data does not make the world more knowable; it merely makes its distortions more precise.This is why most AI systems trained on aggregated EHR data behave like echo chambers — reproducing the biases of documentation, not the biology of disease. In medicine, volume without veracity is not strength but fragility at scale.The Loss Of ContextEvery datum stripped from its origin loses a layer of meaning. When data is extracted, cleansed, and normalized, it often sheds the metadata — time, setting, instrument, decision rationale — that made it interpretable. The process that was supposed to make the dataset objective instead makes it contextually blind. A radiograph taken at 2 a.m. in an ICU cannot be treated as equivalent to one taken at 2 p.m. in an outpatient clinic.Yet that is exactly what “large-scale learning” does: it homogenizes circumstances until only pixels remain. AI that learns from such data cannot tell the difference between physiology and logistics.The Federation AdvantageFederation restores the context that centralization erases. Instead of collapsing local meaning into a global average, federated architectures like Circle Datasets preserve the individuality of each institution’s data while harmonizing their structure. The model learns across differences without erasing them — a distributed epistemology that treats variability as truth, not noise.In this sense, federation is not just a privacy measure; it is an epistemic correction. It allows medicine to learn the way biology learns: locally adaptive, globally coherent.Quality As The New ScaleTrue “size” in healthcare data will no longer be measured in rows or terabytes, but in verifiable completeness per case.A single patient record, longitudinally documented, consistently coded, and contextually validated, is worth more than ten thousand fragments stripped of meaning. Circle Datasets invert the metric: the depth of record replaces breadth of population.This is not downsizing; it is precision scaling — measuring value by integrity, not accumulation. The next era of model development will reward precision of provenance over abundance of data.The Moral Arithmetic Of ScaleScale without governance creates moral distance. When no one can see the patient behind the data, error becomes acceptable and harm becomes invisible. Federation reintroduces proximity — it makes someone responsible for every data contribution. That proximity converts ethics from abstraction into practice.At smaller, governed scales, clinicians rediscover ownership of meaning; systems rediscover accountability; patients rediscover agency. Scale ceases to be an idol and becomes an instrument.Redefining The “BIG” In Big DataMedicine’s great epistemic correction will not come from bigger models but from smaller errors. Federation and provenance allow data to retain its truth at source, transforming “big data” into trusted data — modular, validated, and explainable. The future of learning health systems depends on this redefinition. The question will shift from “How much do we have?” to “How much of what we have is real?” That is not a retreat from ambition. It is the only way to make scale finally intelligent.

The PremiseScience was once the organized skepticism of civilization — a disciplined method for transforming doubt into understanding. But in the modern era, that skepticism has been commodified. Doubt itself has become a product — manufactured, traded, and weaponized. The more uncertain the evidence, the more profitable the debate. In this inverted moral economy, the very act of questioning can serve ignorance as efficiently as it once served truth. The problem is not the presence of uncertainty, but its exploitation. In the industrialized research economy, ambiguity sustains funding; controversy sustains attention; and perpetual revision sustains institutions that thrive on the illusion of progress. Doubt is no longer a stage toward knowledge — it is the business model of modern science. The Distortion This economy rewards paralysis over clarity. Entire fields orbit unsolved questions not because they are insoluble, but because they are lucrative. Each new study extends the horizon of uncertainty just enough to justify the next grant cycle. The rhetorical tools of humility — caveats, limitations, “more research is needed” — become instruments of inertia. Doubt, once epistemic modesty, has been repackaged as moral virtue. Meanwhile, industries external to science — pharmaceuticals, policy think tanks, media outlets — capitalize on this cultivated ambiguity. Manufactured uncertainty becomes a shield for inaction. When doubt can be monetized, truth becomes a threat to market stability. The Consequence The transformation of doubt into commodity corrodes public trust. Citizens encounter a world where every study is contradicted by another, every conclusion softened by caveat. The lay observer no longer distinguishes between scientific caution and institutional evasion. Into that confusion steps ideology, offering certainty as an emotional balm. The tragedy is not merely epistemic but democratic: when the language of science ceases to resolve uncertainty, demagogues will. Within research itself, the moral cost is despair. Scientists trained to seek understanding become artisans of ambiguity. Inquiry becomes a theater of perpetual hesitation — the ritual of deferral masquerading as rigor. The Way Forward Science must reclaim doubt as discipline, not currency. Uncertainty should be bracketed, not broadcast; acknowledged, not amplified. Funding structures can reward closure — synthesis papers, confirmatory meta-analyses, and knowledge integration — as much as new exploration. The moral challenge is to restore courage: the willingness to finish a sentence, to say what is known and bear the weight of saying it. Doubt should again be a doorway, not a dwelling. ReferencesRegenMed (2025). Genuine Medical Research Has Lost Its Way. White Paper, November 2025Oreskes, N., & Conway, E. M. (2010). Merchants of Doubt. Bloomsbury Press. Ioannidis, J. P. A. (2014). How to Make More Published Research True. PLoS Medicine, 11(10). Sarewitz, D. (2018). The Twilight of the Scientific Elite. Issues in Science and Technology, 35(1). Collins, H. M., & Evans, R. (2007). Rethinking Expertise. University of Chicago Press. Funtowicz, S. O., & Ravetz, J. R. (1993). Science for the Post-Normal Age. Futures, 25(7), 739–755. Get involved or learn more — contact us today!If you are interested in contributing to this important initiative or learning more about how you can be involved, please contact us.

We recently had an interesting exchange with neurosurgeon Ahilan Sivaganesan at Hospital For Special Surgery on this exact disconnect. He describes it as the "Twin Sins" of healthcare: Prior authorization acting as both a barrier to high-value care and an enabler of low-value care.The root cause isn't just policy — it's an Engineering Problem.Most systems today are "scraping the exhaust" — attempting to find clinical meaning in billing codes and messy notes after the fact to "guess" at an outcome. This is "schema-on-read," and it creates an inference gap that insurers use to deny innovative treatments like TOPS surgery.To build the Learning Healthcare System Dr. Sivaganesan envisions, we need to move to Structuring at the Source. By defining the structure before the care happens (“schema-on-capture”), we:Mint Ground Truth: Physicians capture high-fidelity, longitudinal evidence as a byproduct of their workflow.Override Static Rulebooks: We provide deterministic proof of value that carriers can no longer ignore.Restore Scientific Sovereignty: The clinician—not the administrator—becomes the primary architect of the evidence.Healthcare doesn't need more "data exhaust." It needs new rails for clinical veracity.

‍When honesty becomes the foundation of liquidity.The Economics of BeliefEvery market begins with faith — that what is exchanged will be honored. But modern medicine trades in abstractions that faith can no longer sustain: algorithms we cannot audit, datasets we cannot trace, and claims we cannot verify. The market for truth collapsed not through corruption, but through opacity. When provenance disappears, credit follows. Circle Coin repairs the balance sheet of belief by making honesty fungible. It transforms truth from moral ornament to financial infrastructure. The Failure of ReputationInstitutions once guaranteed integrity through their names — academic hospitals, journals, regulators. Today, those reputations function like overdrawn accounts: they spend trust faster than they earn it. Circle’s distributed model replaces institutional reputation with transactional proof. Each verified event — a patient’s consent, a dataset’s validation, a physician’s attestation — accrues intrinsic credit recorded permanently on the network. Reputation becomes measurable and portable, because trust is no longer declared; it is demonstrated. Proof as MediumIn classical finance, currency is the medium through which value moves; in the Circle system, proof is that medium. Every exchange — whether economic, clinical, or informational — passes through a layer of verification. This transforms ethics into a market function. The cost of honesty becomes zero, the cost of deceit infinite. Each Circle Health Coin (CHC) thus represents not merely ownership of data, but the liquidity of integrity — proof that can circulate, compound, and clear.The Decentralization of TrustCentralized validation (peer review, audit committees, IRBs) cannot scale to modern information velocity. Federation solves this bottleneck: every node becomes both participant and verifier. Trust moves horizontally, at the speed of consensus. This networked verification creates ethical liquidity — the ability of truth to flow freely without dependence on central intermediaries. Where honesty was once bureaucratic overhead, it is now the shortest path between two points. The Yield of IntegrityTruth, when structured properly, generates yield. Verified datasets lower compliance costs, increase clinical reliability, and attract capital investment. Every act of verification enriches the ecosystem — a compounding dividend paid in confidence. Circle’s architecture captures this yield through tokenization: each CHC represents a share of the moral productivity of the network. Integrity becomes not only virtue but asset class. The Moral Outcome Currency began as a trust technology; Circle restores it to that purpose. It redefines value as verified honesty, and markets as instruments of moral alignment. In the Circle economy, wealth no longer accumulates through possession, but through proof. The oldest promise of commerce — that truth will be honored — becomes, at last, a protocol. Selected References RegenMed (2024). Circle Datasets: The Foundation For Circle Health Coins.OECD (2024). Trust as Economic Infrastructure. Deloitte (2024). The Liquidity of Integrity. European Commission (2025). Verification Economies in Health Data Markets. Get Involved Or Learn More — Contact Us Today!If you are interested in contributing to this important initiative or learning more about how youcan be involved, please contact us.